Multimodal monitoring: head injury management using Sjv[O.sub.2] and LICOX.
Head trauma results in 500,000 hospital admissions (Archibald, S.J., Fleckenstein, W., Littlejohns, L., O'Grady, J., & Trimble, B., 2001) and represents more than two thirds of in-hospital deaths annually. It carries a high mortality rate among young Americans today (Sarrafzadeh et. al., 2001). Brain injuries are a continuous challenge on both a national and global scale. Without adequate intervention, head injuries lead to severe physical and mental disability, as well as death. The current cost of treatment and rehabilitation of one severely brain-injured patient is more than $300,000 (Haselman & Fox, 2000). This cost does not include the eventual long-term cost of care needed after a patient is discharged from a rehabilitation facility.
Graham, Lawrence, and Adams (1988) contend that ischemic changes were found postmortem in 70% of injured brains without previous evidence of clinical, pathological, or radiological changes indicative of increased intracranial pressure (ICP). Adverse effects (e.g., hypoxemia, hypotension, and elevated ICP) may cause secondary cerebral ischemia. Graham et al. (1998) suggest these insults remain undetected with the use of current technology and may worsen patient outcomes. In addition, concomitant multiple trauma places the patient at risk for cerebral ischemia because of other complications, including hyperglycemia secondary to physiologic stress, hypovolemia, and shock. The brain consumes close to 20% of the body's oxygen (Maloney-Wilensky et al., 2002). It does not contain an oxygen reservoir from which to draw during acute illness. This further emphasizes the fact that the brain is extremely fragile, because of its inability to rely on a steady blood flow after a traumatic injury. Therefore, it is important that initial care is directed toward life-threatening injuries that may affect brain oxygen supply and demand.
Multimodal intracranial monitoring provides useful observation of specific changes as well as an opportunity for early intervention. LICOX[R], which evaluates local ICP, brain temperature, and brain tissue oxygenation (Pbt[O.sub.2]) values, as well as the jugular venous bulb (Sjv[O.sub.2]), which monitors global brain tissue oxygen consumption, are the two monitors in use today. Multimodal, or multitechnique, monitoring (van den Brink, et al. 1998) involves the use of LICOX together with the Sjv[O.sub.2] monitors to synergize beneficial information regarding treatment for a particular patient suffering from a traumatic brain injury. Other current technology exists to gather information and guide treatment in brain-injured patients such as ICP monitors, ventriculostomy drainage systems, as well as continuous bedside electroencephalograms (EEGs). By including the use of Pbt[O.sub.2] and Sjv[O.sub.2] monitoring, intracranial hemodynamics status can be accurately obtained. This article explores the capabilities of both the LICOX and the Sjv[O.sub.2] catheters in detecting cerebral ischemia, as well as implications for practice and future potential in critical care management.
Current Cerebral Function Monitoring and Management
Head Trauma Complications
Enhancing cerebral blood flow (CBF) in a traumatic brain-injured patient becomes complicated because of continuous metabolic demands and changes. Hypoxia, for example, secondary to hypoperfusion or an underlying pulmonary process, may indirectly affect the oxygenation of brain tissue due to changes in CBF. Vasodilation decreases CBF and perfusion when decreased oxygen and increased carbon dioxide levels result from poor ventilation. In addition to hypoxia and hypoperfusion, cerebral edema may develop and cause an elevation in ICP that may further impede oxygen delivery to the brain. For accurate management, these adverse events are best monitored invasively in a traumatic brain injury.
ICP Versus CPP
Cerebral perfusion pressure (CPP), a parameter that is a calculated value from ICP and mean arterial pressure (MAP) values, is an indicator of general cerebral perfusion, as well as CBF. The debate is whether to use ICP or CPP targeted management to maintain adequate CBF, because CPP is a more reliable indicator of cerebral oxygenation than ICP alone. According to van den Brink et al. (1998), CPP is affected as fluctuations in MAP and ICP occur, regardless of whether these values are within normal range for the patient. Treatments can be used to maintain both the ICP and CPP to support adequate CBF. This is important to provide adequate oxygenation and CBF to the brain (Robertson et al., 2001).
ICP and CPP values are currently used to evaluate and guide treatment in head trauma. Although they provide useful information, these parameters provide only limited information about brain tissue perfusion and oxygenation. For this reason, both LICOX and Sjv[O.sub.2] monitors are available to provide up-to-date information regarding the status of brain tissue oxygenation and to indicate the need for early intervention and treatment. It is important to note that over time, immediate and long-term management varies depending on the stability of the brain injury. Brain oxygenation and perfusion values such as CPP, ICP, Pbt[O.sub.2], and Sjv[O.sub.2] may eventually normalize without a change in neurological function. At that point, it is important to prevent overtreatment of the initial brain insult and begin appropriate rehabilitation therapy.
ICP and calculated CPP are currently used to manage patients with head injuries. These are less specific, as well as less sensitive, indicators of adequate cerebral perfusion and oxygenation. With the use of LICOX and Sjv[O.sub.2] monitors, information regarding intracranial hemodynamics not only includes ICP measurements but also actual brain tissue oxygenation and consumption via continuous bedside monitor readings. This allows efficient management of viable brain tissue to optimize a patient's future recovery.
Multimodal Monitoring LICOX (Pbt[O.sub.2]) Monitor
Changes in ICP values alone do not accurately depict poor cerebral blood flow or oxygenation deficits to brain tissue. Pbt[O.sub.2] monitoring via the LICOX system is a valuable assessment tool, because it provides early detection of impending ischemic events (Meixensberger, Dings, Kuhnigk, & Roosen, 1993). LICOX provides information on early changes in cerebral oxygenation, perfusion, and temperature before ICP changes. LICOX measures regional rather than global areas of arterial oxygenation and perfusion when placed in the penumbra surrounding the injury. Normal Pbt[O.sub.2] values range from 37 to 47 mm Hg. A value below 37 mm Hg is indicative of a swollen cortex and possible ischemia that could lead to permanent neuronal injury (Valadka, Gopinath, Contant, Uzura, & Robertson, 1998).
When Pbt[O.sub.2] values decrease, areas of brain tissue may be deprived of adequate oxygenation. Causes of low Pbt[O.sub.2] values include seizures, cerebral edema, intracranial hemorrhage, as well as intracranial hypertension. A critical low range is considered to be between 5 and 10 mm Hg (Valadka et al., 1998). Valadka and colleagues found that a Pbt[O.sub.2] of [less than or equal to] 5 mm Hg within the first 24 hours results in death as compared with a Pbt[O.sub.2] of > 5 mm Hg during the first 24 hours. Van den Brink et al. (2000) state that a Pbt[O.sub.2] <5 mm Hg for 30 minutes poses a 50% risk of death. Moderately hypoxic levels of <10 mm Hg are also associated with a 50% mortality risk if this level persists for more than 1 hour and 45 minutes. Patients with Pbt[O.sub.2] levels of < 15 mm Hg in the presence of mild hypoxia have a 50% chance of death if left untreated up to 4 hours or more. Overall, the longer the patient's Pbt[O.sub.2] levels are <15 mm Hg, the greater the chance of a fatal outcome. In contrast, a Pbt[O.sub.2] of >35 mm Hg is associated with a good recovery, whereas those patients with levels of Pbt[O.sub.2] 26-35 mm Hg remained disabled, and lastly those patients with a Pbt[O.sub.2] of <25 mm Hg were linked to an early death or persistent vegetative state (Zauner et al., 1998).
LICOX plays an important role in the implementation of multimodality monitoring in intensive care units. The LICOX system is supplied with a temperature, oxygenation, and ICP probe--all three monitors are incorporated into one device and inserted at the same time, and in the same place. The temperature probe is considered by the LICOX manufacturer to have an accuracy rate of up to 0.2[degrees]C of the current temperature of any tissue. In head trauma, the probe can read in Celsius up to 0.8[degrees] higher than the core temperature. This temperature probe is considered to be accurate for up to 5 days. LICOX is also capable of obtaining extensive and precise Pbt[O.sub.2] values from regional areas of the brain, as well as a global ICP measurement.
ICP and brain tissue oxygenation readings may be followed simultaneously. However, these numbers may not correlate, which is why the oxygenation probe is a valuable tool in the head injured population. For example, a low or fluctuating Pbt[O.sub.2] may or may not be associated with an increase in ICP. This reinforces the fact that changes are noted earlier with the LICOX probe versus an ICP monitor alone and allows for a comparison between early versus late detection of cerebral changes in oxygenation. However, in the case of an elevated ICP, values in the face of a normal Pbt[O.sub.2] reading may imply a malfunction of the autoregulatory system within the brain and a hyperemic state that increases CBF such as when a patient is febrile (Stiefel et al., 2003). In this case, an elevated ICP may not reflect impending cerebral ischemia. Normal monitoring parameters, as well as brain tissue values detected by the LICOX monitor, are found in Table 1.
LICOX Placement Issues
Accurate placement of LICOX catheters is crucial to obtain reliable readings. Catheters are usually placed on the right side in the subarachnoid space of the frontal lobe with the oxygen probe extending into the white matter. Placement on the left may cause injury to the speech center of the brain. A computed tomography (CT) scan can be used to locate the area of damage, and then the LICOX catheter may be placed within the penumbra of the injury. If the area of vasospasm or blood clot is thicker on the right, then the catheter will be placed on the right, and if the area of thicker blood is on the left, then it is placed on the left. If the area of vasospasm or injury cannot be accurately determined, such as with diffuse axonal injuries, then the LICOX is placed on the right (Maloney-Wilensky et al., 2003). The LICOX probe should be placed 14 mm from other probes such as a ventricular drain. Brain tissue may take up 120 minutes to settle before readings may be obtained. Next, an oxygen challenge test should be performed to check the reliability of the LICOX. This is achieved by setting the ventilator to deliver 100% oxygen to the patient, and if the probe is working correctly, the Pbt[O.sub.2] will respond by increasing in value. If no response occurs, a head CT scan should be completed to confirm placement (Maloney-Wilensky et al.). A probe rarely produces false values because the oxygen sensor is located <5 mm from the distal end of the probe (Valadka, Gopinath, Contant, Uzura, & Robertson, 1998).
Pbt[O.sub.2] values vary greatly depending on placement of the LICOX, as well as insults during placement into brain tissue. A patient may have a good recovery because viable tissue may exist in surrounding areas despite low Pbt[O.sub.2] readings secondary to localized placement in the penumbra of the injury, because viable tissue may exist in surrounding areas. Low readings may result when placement of a probe causes microvascular compression within the injury penumbra (Bruzzone, Dionigi, Bellinzona, Imberti, & Stocchetti, 1998). Furthermore, placement in contusions, infarcts, and hemorrhagic areas may adversely affect oxygen measurements and may cause display of low readings that may be refractory to treatment. As a result, local placement by LICOX may potentially lead to either overtreatment or undertreatment of viable brain tissue because of the limited information provided on surrounding areas.
Conversely, placement with an undamaged area is beneficial as it reflects changes in global oxygenation. Pbt[O.sub.2] readings are indicative and influenced by oxygen exchange within the capillary beds and by the diameter of these vessels that surround the catheter (van den Brink et al., 1998). After placement, the probe takes up to 80 minutes to adapt to brain tissue and record accurate data (van Santbrink, Maas, & Avezaat, 1996). A malfunctioning catheter may provide low readings for 6 hours from the time of initial insertion and calibration despite increasing oxygen delivery via ventilator (Pollina & Gibbons, 1999). It is fortunate that the LICOX is stable in brain tissue for up to 16 days, and therefore recalibration is unnecessary (Pollina & Gibbons, 1999). Absolute contraindications for placement of LICOX are coagulopathy, defined as a platelet count of <50,000, and insertion through a craniotomy bone flap as it is without stability. Fortunately, the actual risk of infection or a contusion produced by the placement of a LICOX monitor is relatively low at about < 2% (Maloney-Wilensky et al., 2003).
Schell and Cole (2000) contend that monitoring of oxygenation of cerebral venous outflow via the jugular vein has been a topic under investigation for more than 50 years. Sjv[O.sub.2] monitoring was first developed and applied to the care of head-injured patients in the 1980s (Gopinath, Valadka, Uzura, & Robertson, 1999). It measures global cerebral oxygenation supply and demand by measuring total venous brain tissue extraction of oxygen. Normal Sjv[O.sub.2] values are 60%-80%, whereas a reading of <50%-55% is considered critical. Sjv[O.sub.2] monitors are able to detect desaturations within the first 48 hours of a brain injury as they are mainly used on a short-term basis (Clay, 2000). Fluctuating Sjv[O.sub.2] values can guide the management of sedation, fluid administration, a barbiturate-induced coma, as well as hyperventilation strategies. Over time, effective implementation of the Sjv[O.sub.2] monitor could prevent adverse outcomes in patients who require continuous life support.
Cerebral extraction of oxygen, or Sjv[O.sub.2] monitoring, has been proven to be beneficial in managing head injuries in the acute phase. The acute phase, according to Bouma et al. (1991 as cited in Cruz, 1998), is the first 12 hours since the initial brain injury occurred. After 12 hours, acute intracranial hypertension (ICH) may develop, reflected as low Sjv[O.sub.2] values (i.e., <50%). Values obtained by the Sjv[O.sub.2] catheter are relied on over a short time period usually less than 5 days. (Kiening, Unterberg, Bardt, Schneider, & Lanksol, 1996). However, the initial management, 24 to 48 hours following a head injury, is crucial to outcome and survival. In multiple trauma patients, hypotension secondary to blood loss complicates management. In patients without a significant extracranial blood loss, ICH may develop because of intracranial hemorrhage and may be refractory to medical management. These patients usually require maximum medical therapy and hyperventilation strategies or an emergent craniotomy to prevent cerebral ischemia.
Cruz states that the Sjv[O.sub.2] monitor, along with a calculated CPP, is useful in guiding management of acute ICH (1998). Without an Sjv[O.sub.2] catheter, monitoring CPP alone does not reflect adequate brain oxygenation needs as well as impending ischemia (Cruz). ICP and CPP are valuable indicators of cerebral blood flow; however, these numbers alone do not accurately interpret true cerebral hemodynamics during the acute stages of a brain injury. Cruz indicates that when ICP is >30 mm Hg and CPP is optimized, the brain tissue oxygenation values continue to decline despite supportive vasopressor and metabolic therapy. Furthermore, there were patients in the CPP or control group who required at least 10 days versus those in the Sjv[O.sub.2] and CPP group, who required only 6 days or less of acute ICH management. Those in the control group without Sjv[O.sub.2] monitoring could not benefit from hyperventilation because brain oxygenation values were not monitored and cerebral ischemia would be less detectable. The optimization of hyperventilation assisted in normalizing Sjv[O.sub.2] values, as well as cerebral glycemic and oxygenation needs. Monitoring Sjv[O.sub.2] improves overall patient outcomes by decreasing the need for long-term vasopressors and allowing the use of hyperventilation therapy to prevent recurrence of unstable episodes of ICH and potential cerebral ischemia.
Placement of Sjv[O.sub.2]
Optimal placement of the Sjv[O.sub.2] catheter is based on several factors. The left and right jugular veins are asymmetrical because the right internal jugular is larger in diameter. As a result, venous blood from both cerebral hemispheres drains unequally through the jugular veins with up to a 10% difference in readings. Most patients' head injuries are monitored with the Sjv[O.sub.2] catheter inserted on the ipsilateral side of the head injury. However, the larger right jugular vein facilitates insertion on that side. In the case of a bilateral insult, the Sjv[O.sub.2] is placed in the right internal jugular vein. Normal monitoring parameters as well as indications for treatment for Sjv[O.sub.2] are found in Table 1.
Advantages and Disadvantages of Sjv[O.sub.2] Placement
The accuracy of the Sjv[O.sub.2] catheter is dependent on several factors. These factors are the position of the catheter and patient, as well as attention to light intensity levels of the catheter, which all lead to the need for continuous recalibration. It is placed above C1 via a large intravenous catheter and is checked by X ray for correct placement to minimize extracerebral contamination (Fig 1). The Trendelenburg position is necessary for placement, and therefore patients with unstable ICPs may not tolerate insertion unless placed under appropriate sedation or in surgery. At times, a Doppler is used (Clay, 2000) to minimize placement difficulty. Arterial blood gases are drawn to calibrate the Sjv[O.sub.2] catheter, which is connected to a bedside monitoring device similar to a continuous cardiac output monitor. The catheter frequently lodges against the vessel, or the light at the end of the probe may malfunction and display low readings. Contraindications include cervical spine injury, brainstem injury, neck trauma, presence of a tracheostomy, coagulopathy, as well as jugular venous occlusion or malformation. Complications from placement include pneumothorax, carotid artery puncture, nerve injury, infection, thrombosis, and increased ICP secondary to obstruction of venous return (Schell & Cole, 2000). Troubleshooting complications associated with both the Sjv[O.sub.2] and the LICOX monitor are found in Table 2.
[FIGURE 1 OMITTED]
The total package to place a Pbt[O.sub.2] (LICOX) monitor including the access tray is approximately $16,000. The cost of the catheter alone is about $900. Each of the catheters may be ordered separately as well, if needed. Separate access trays that are used by neurosurgeons, as well as intensivists, to place a LICOX at the bedside cost $194. These trays include the sheaths, introducers, and a mechanical drilling device to place the Pbt[O.sub.2] probe. The bedside monitors cost approximately $15,000 and the cables that connect the intracranial oxygen and temperature probes to the monitor are included in this cost. These cables may be replaced separately from the box if displaced or malfunctioning but are costly as well. There are no daily charges except for maintenance care of the site with daily dressing change kits that are relatively inexpensive. LICOX has been approved by the FDA to remain in place for up to 5 days. A head CT scan is necessary to confirm placement, which is an added cost to the use of LICOX.
The Sjv[O.sub.2] monitor is less expensive than LICOX, and the total price for the catheter is about $200-250. This does not factor in the use of a central-line kit as well as the transducer, bedside oxygenation monitor, occlusive dressing, and the use of several arterial blood gas syringes frequently used on a daily basis to calibrate the machine. Although, the Sjv[O.sub.2] monitor is less expensive than the LICOX monitor, the two monitors are most beneficial when used together. They provide synergistic information when managing any patient with a severe brain injury.
CPP/CBF Management Using Sjv[O.sub.2] and LICOX
Both the LICOX (Pbt[O.sub.2]) and the Sjv[O.sub.2] monitor are indicators of cerebral oxygenation and consumption. However, Sjv[O.sub.2] is considered a more sensitive indicator of cerebral oxygenation and CBF than Pbt[O.sub.2] due to its capability to monitor global cerebral tissue oxygenation (Schell & Cole, 2000). In many cases, LICOX is the preferred choice for monitoring head injuries if it is impossible to place both monitors. At times, Sjv[O.sub.2] catheters display at or above normal values during hypoxic events, which indicates increased extracerebral contamination and displays falsely elevated Sjv[O.sub.2] values that reflect an increased systemic versus cerebral influence secondary to decreased oxygen extraction in areas of ischemia.
Pbt[O.sub.2] is considered an acceptable measurement of cerebral oxygenation for guiding CPP management to optimize CBF as well. Although studies continue to determine the correlation among ICP, CPP, and Pbt[O.sub.2] levels, LICOX detects poor oxygen perfusion in brain tissue before changes in ICP occur (Artru, Perret-Liaudet, Charlot, & Mottolese, 1998). For example, LICOX monitors placed in brain tissue away from the site of injury have detected a decrease in oxygen levels even when the ICP is within normal limits (Artru et al.). A second study by Hartl and colleagues (1997) showed that when CPPs are low and ICPs are decreased by administering mannitol IV, Pbt[O.sub.2] levels remain unchanged. A case report by Stiefel et al. (2003) also states that elevated ICPs may also be correlated with normal Pbt[O.sub.2] values; therefore aggressive treatment is not necessary as signs of cerebral hypoxia are not apparent.
Sjv[O.sub.2] and LICOX probes are invaluable tools when used together to depict a comprehensive and realistic outlook of a patient's cerebral oxygenation and metabolism in the acute phase of head trauma. A correlation was found between CBF (CPP), the Sjv[O.sub.2], and the Pbt[O.sub.2] monitors in the prevention of cerebral hypoxia (Kiening, et al. 1996). This study found that when the CPP is <60, both the Sjv[O.sub.2] and LICOX readings would begin to decline as well. Whereas at a CPP of >60, both Pbt[O.sub.2] and Sjv[O.sub.2] correlated indicating adequate cerebral oxygenation and perfusion. However, as previously stated by Cruz (1998), CPP may be optimized in the face of an elevated ICP, yet brain tissue oxygenation is compromised because of increased CBF and persistent ICP.
Implications for Nurses
The first 24 hours after a traumatic brain injury or intracranial bleed is the most critical time to monitor changes in brain tissue oxygenation. Conventional treatment without Sjv[O.sub.2] and LICOX monitoring includes sedation, muscle paralysis, hypothermia, cerebral spinal fluid drainage via a ventriculostomy, hyperventilation, monitoring arterial blood gases to keep PaC[O.sub.2] at 35 mm Hg or less; administering diuretics; and lastly, using vasopressors to maintain a CPP of >70. For the treatment of refractory elevated ICPs, a patient may be placed into a barbiturate coma using a bedside EEG. In addition to vasopressors, judicious use of fluid replacement may be an important tactic as well to keep a patient closer to euvolemic than hypervolemic. This may be achieved through the administration of blood products as well as hypertonic or normal saline and other plasma expanders such as hetastarch. Nurses, along with respiratory therapists, can collaborate at the bedside to directly enhance brain tissue oxygenation content by increasing the amount of inspired oxygen on the ventilator as well. In general, the use of both the LICOX and Sjv[O.sub.2] monitors provides immediate feedback at the bedside from which nurses can effect changes in treatment.
Current and Future Research LICOX
Several issues remain regarding the LICOX monitor. Global changes are less frequently detected with LICOX because of local placement of the catheter. However, if this monitor is placed in healthy tissue versus the injured areas, the oxygenation levels will reflect potential secondary insults to intact brain tissue. Placement in an injured area may result in overtreatment of a known ischemic area that could place surrounding healthy tissue at risk. Hyperventilation with 100% oxygen for an elevated ICP can cause a decrease in the Pbt[O.sub.2] reading and this in turn may cause secondary ischemic events in viable brain tissue (Fandino, Stocker, & Prokop, 1999). In contrast, hyperoxygenation alone drastically improves brain tissue oxygenation in the setting of a low CPP (Fandino et al.). Bardt et al. 1998 state that hypoxic episodes of less than 30 minutes defined as Pbt[O.sub.2] levels <10 mm Hg with a Glasgow coma scale (GCS) of >4-5 had more favorable outcomes than those who had hypoxic episodes of greater than 30 minutes with a Pbt[O.sub.2] of <10. These patients either died or had unfavorable outcomes at the time of discharge and at 6 months. Long-term outcomes such as improved neurological functioning using LICOX are relatively unknown in severe head injuries as well as other pathologies.
Future research in the use of Sjv[O.sub.2] is required. Despite short-term use of Sjv[O.sub.2], long-term morbidity and mortality associated with this monitoring in critical care units have not been proven except when Sjv[O.sub.2] is used in conjunction with hyperventilation strategies or the LICOX to prevent cerebral ischemia (Schell & Cole, 2000). New uses for Sjv[O.sub.2] monitoring include adult and pediatric cardiac surgery patients. Neurological function is important to monitor during the rewarming phase of cardiac surgery; a decrease in Sjv[O.sub.2] can indicate impending ischemia. Patients undergoing an intracranial aneurysm clipping benefit from Sjv[O.sub.2] monitoring by monitoring response to induced hypotension at the time of clipping, thereby minimizing hypoperfusion and hypoxia to brain tissue (Schell & Cole).
Ultimately, the prevention of secondary brain tissue ischemia is the goal. Therefore, how oxygenation and perfusion consumption are best measured continues to be debated. It is not clear whether a low Pbt[O.sub.2] level within the first 24 hours of injury is indicative of decreased CBF versus ischemia or is reflecting an increased uptake of oxygen in potentially viable tissue (van den Brink et al., 2000). The lower end of the threshold is 25 mm Hg; however, new limits may be set depending on future data regarding patient outcomes and survival. As a result, multimodal monitoring over time provides information on brain tissue oxygen supply and demand measured by both the LICOX and Sjv[O.sub.2] catheters.
Multimodal monitoring facilitates prevention and timely management of head injuries. Each intensive care unit (ICU) patient requires unique management because of multiple underlying medical problems, which constantly challenge practitioners as they consider treatment options. Hypoxia, hypoperfusion, and infection are frequent complications and can compound patients' ICU course from hours to weeks. Aggressive treatment to reverse these problems is necessary to prevent unnecessary secondary cerebral ischemia. Together LICOX and Sjv[O.sub.2] catheters provide valuable and synergistic information to evaluate, on both a local and global level, head injury hemodynamics. Appropriate management steps may then be taken to avoid future adverse neurological outcomes.
Table 1. Relationship Between LICOX and Sjv[O.sub.2] Indications (Average CBF: 50-55 ml/100 gm Sjv[O.sub.2] brain tissue/min) (global/venous) Normal values 55%-75% Critical values < 50% Global decrease in CBF Decrease (anemia, ischemia, hypotension, hypovolemia, hypoxia, ICP) Regional decrease in CBF and Normal or increase [O.sub.2] delivery (ischemia) Cerebral [O.sub.2] demand > Decrease (54%) (Due to supply (seizures, ICH, increased [O.sub.2] extraction) pain, agitation, fever) Cerebral [O.sub.2] supply > demand (hyperemia, increase Increase (> 90%) in PaC[O.sub.2], increase in CBF, hyperoxia, anesthesia, paralysis) Hyperventilation management Increase Sensitivity for ischemia 63.5% Indications (Average CBF: 50-55 ml/100 gm Pbt[O.sub.2] brain tissue/min) (local/arterial) Normal values 37-47 mm Hg Critical values < 25 mm Hg Global decrease in CBF Decrease (anemia, ischemia, hypotension, hypovolemia, hypoxia, ICP) Regional decrease in CBF and Decrease [O.sub.2] delivery (ischemia) Cerebral [O.sub.2] demand > Decrease (< 20 mm Hg) supply (seizures, ICH, (Before increase [O.sub.2] pain, agitation, fever) delivery via ventilator, Fi[O.sub.2]) Cerebral [O.sub.2] supply > demand (hyperemia, increase Increase (> 40 mm Hg) in PaC[O.sub.2], increase in CBF, hyperoxia, anesthesia, paralysis) Hyperventilation management Increase (depends on location of LICOX) Sensitivity for ischemia 69.7% Sources: Archibald, Fleckenstein, Littlejohns, O'Grady, J., & Trimble, 2001; Bader, Litflejohns, & March, 2003," Clay, 2000, Littlejohns, Badei; & March, 2003, Maloney-Wilensky et al., 2003, Meixensberger, Dings, Kuhnigk, & Roosen, 1993; Meixensberger, Jager, Dings, Baunach, & Roosen, 1997, Schell & Cole, 2000, Van den Brink et al., 2000. Table 2. Pbt[O.sub.2] and Sjv[O.sub.2] Monitoring: Troubleshooting Tips Pbt[O.sub.2] and Sjv[O.sub.2] Troubleshooting Tips Equipment Malfunction * Broken cable/catheter/light * Obtain backup equipment. sensor malfunction * Inaccurate calibration in vitro * Check calibration machine. or in vivo Recalibrate Sjv[O.sub.2] with ABG. * Artifact * May take up to 6 hours to calibrate. Minimize excessive movement, use appropriate sedation. * Power supply interruption: LICOX * Reposition head/neck (if spine restarts automatically, no cleared). Reposition catheter recalibration necessary (may be against vessel wall). Catheter Dislodgement * Secure catheter at site/ stabilize for transports. * Reconfirm placement with head CT for LICOX or head/neck X ray for jugular venous bulb Placement Complications Treatment/Management Sjv[O.sub.2] * Hemorrhage with placement in * Optimally, correct coagulation carotid artery; hematoma at times before placement, platelet site. count < 50,000 contraindicates placement of intracerebral catheters * Puncture through jugular vein, * Administer clotting factors as obstruction of venous return needed. (increase in ICP), thrombosis, * Protect airway and draw ABGs to nerve injury, infection recalibrate with CCO monitor (if Sjv[O.sub.2]). Pbt[O.sub.2] * Inaccurate or low readings after * Increase Fi[O.sub.2] on vent to placement, infection 100% x 5 minutes, if no improve- ment; head CT scan to check placement. Infection * Maintain exit site of catheter with dressing, clean site. * Remove and replace in new area if needed. Sources: Archibald, Fleckenstein, Littlejohns, O'Grady, & Trimble, 2001; Bader, Littlejohns, & March, 2003; Littlejohns, Bader, & March, 2003; Maloney-Wilensky et al., 2003; Meixensberger Dings, Kuhnigk & Roosen, 1993; Meixensberger, Jager Dings, Baunach, & Roosen, 1997; Van den Brink et al, 2000; Can Santbrink & Maas, 1996.
Archibald, S.J., Fleckenstein, W., Littlejohns, L., O'Grady, J., & Trimble, B. (2001). LICOX CMP Brain Oxygen Monitoring System Operations Manual [A literature review and clinical summary report]. Integra NeuroSciences, pp.1-16.
Artru, F., Jourdan, C., Perret-Liaudet, A., Chariot, M., & Mottolese, C. (1998). Low brain tissue oxygen pressure: Incidence and corrective therapies. Neurological Research, 20, Supplemental S48-S51.
Bader, M.K., Littlejohns, L.R., & March, K. (2003). Brain tissue oxygen monitoring II. Implications for critical care teams and case study. Critical Care Nurse, 23(4); 29-44.
Bardt, T.F., Unterberg, A.W., Hartl, R., Kiening, K.L., Schneider, G.H., & Lanksch, W.R. (1998). Monitoring of brain tissue P[O.sub.2] in traumatic brain injury: Effect of cerebral hypoxia on outcome. Acta Neurochir-Supplement, 71, 153-156.
Bruzzone, P., Dionigi, R., Bellinzona, G., Imberti, R., & Stocketti, N. (1998). Effects of cerebral perfusion pressure on brain tissue P[O.sub.2] in patients with severe head injury. Acta Neurochirurgica Supplement, 71, 111-113.
Bonma, G.J., Muizelaar, J.P., Choi, S.C., Newton, P.G. & Young, H.F. (1991). Circulation and metabolism after severe brain injury: The elusive role of ischemia. Journal of Neurosurgery, 75, 685-693.
Clay, H.D. (2000). Validity and reliability of the Sj[O.sub.2] catheter in neurologically impaired patients: A critical review of the literature. Journal of Neuroscience Nursing, 32(4), 194-202.
Cruz (1998). The first decade of Continuous monitoring of jugular bulb oxyhemoglobin saturation: Management strategies, Critical Care Medicine 26(2), 344-351.
Graham, D., Lawrence, A., & Adams, J. (1988). Brain damage in fatal non-missile head injuries with high intracranial pressures. Journal of Clinical Pathology, 41, 34-37
Fandino, R., Stocker, S., & Prokop, H-G. (1999). Correlation between jugular bulb oxygen saturation and partial pressure of brain tissue oxygen during C[O.sub.2] and [O.sub.2] reactivity tests in severely head-injured patients. Acta Neurochirurgica, 141, 825-834.
Hartl, R., Bardt, T.E, Kiening, K.L., Sarrafzadeh, A.S., Schneider, G.H., & Unterberg, A.W. (1997). Mannitol decreases ICP but does not improve brain-tissue Pbt[O.sub.2] in severely head-injured patients with intracranial hypertension. Acta Neurochirurgica Supplement, 70, 40-42.
Haselman, M., & Fox, S. (2000). Microsensor and microdialysis technology: Advanced techniques in the management of severe head injury. Critical Care Nursing Clinics of North America, 12(4), 437-446.
Kiening, K.L., Unterberg, A.W., Bardt, R.F., Schneider, G., & Lanksch, W. (1996). Monitoring of cerebral oxygenation in patients with severe head injuries: Brain tissue P[O.sub.2] versus jugular vein oxygen saturation. Journal of Neurosurgery, 85, 751-757.
Littlejohns, L.R., Bader, M.K., & Marck, K. (2003). Brain tissue oxygen monitoring in severe brain injury: Research and usefulness in critical care. Critical Care Nurse, 23(4), 17-25.
Maloney-Wilensky, E., Bloom, S., Leichter, D., Verdiramo, A.M., Ledwith, M., Stiefel, M., et al. (2003). Brain oxygen monitoring system: LICOX CMP Continuous determination of oxygen partial pressure (Pbt[O.sub.2]) and brain tissue temperature using the LICOX CMP monitoring system: Brain tissue oxygen practice guidelines. Unpublished manuscript.
Maloney-Wilensky, E., Fitzpatrick, M., Sicoutris, C., Bloom, S., Henry, M., Leichter, D., et al. (2002). A multidisciplinary team approach to implementation of new clinical technology: Brain tissue oxygenation multi-modality monitoring system. Journal of Trauma Nursing, 9(4), 96-102.
March, K. (2000). Intracranial pressure monitoring and assessing intracranial compliance in brain injury. Critical Care Nursing Clinics of North America, 12(4), 429-436.
Meixensberger, J., Dings, J., Kuhnigk, H., & Roosen, K. (1993). Studies of tissue P[O.sub.2] in normal and pathological human brain cortex. Acta Neurochirurgica Supplement, 59, 58-63.
Meixensberger, J., Jager, A., Dings, J., Baunnach, S., & Roosen, K. (1997). Quality and therapeutic advances in multi-modality neuromonitoring following head injury. In Bauer, B.L. and Kuhn, T.J. (Eds.), Severe head injuries (pp. 99-108). Berlin: Springer Verlag.
Pollina, J. & Gibbons, K.J. (1999). local monitoring of celebral oxygenation: A new and useful tool? Critical Care Medicine, 27(11), 2569-2570.
Robertson, C.S. (2001). Management of cerebral perfusion pressure after traumatic brain injury. Anesthesiology, 95(6), 1513-1517.
Sarrafzadeh, A.S., Peltonen, E.E., Kaisers, U., Kuchler, I., Lanksch, W.R., & Unterberg, A.W. (2001). Secondary insults in severe head injury--Do multiple injured patients do worse? Critical Care Medicine, 29(6), 1116-1123.
Schell, R., & Cole, D.J. (2000). Cerebral monitoring: Jugular venous oximetry. Anesthesia & Analgesia, 90(3), 559-566.
Stiefel, M.F., Verdiramo, A.M., Bloom, S., Maloney-Wilensky, E., Grady, S., Gracias, V., et al. (2003). Multi-modality monitoring in the management of refractory intracranial hypertension: A case report. Unpublished manuscript submitted for publication.
Valadk, A.B., Gopinatu, S.P., Contact, C. F. Uzura, M., & Robertson, C.S. (1998). Relationship of brain tissue P[O.sub.2] to outcome after severe head injury. Critical Care Medicine, 26:1576-1581.
van den Brink, W.A., van Santbrink, H., Avezaat, C.J., Hogesleeger, C., Jansen, W., Kloos, L.M., et al. (1998). Monitoring brain oxygen tension in severe head injury: The Rotterdam experience. Acta Neurochiurgica Supplement, 71, 190-194.
van den Brink, W.A., van Santbrink, H., Steyerberg, E.W., Avezaat, C.J., Carmona-Suazo, J.A., Hogesteeger, C. et al. (2000). Brain oxygen tension in severe head injury. Neurosurgery, 46(4), 868-878.
van Santbrink, H., Maas, A., & Avezaat, C.J.J. (1996). Continuous monitoring of partial pressure of brain tissue oxygen in patients with severe head injury. Neurosurgery, 38(1), 21-31.
van Santbrink, H. & Maas, A.I.R. (1996). Continuous monitoring system operations manual. Neurosurgery, 46(4), 868-878.
Zauner, A., Doppenberg, E., Soukup, J., Menzel, M., Young, H.F., & Bullock, R. (1998). Extended neuromonitoring: New therapeutic opportunities? Neurological Research 20, S85-S90.
Questions or comments about this article may be directed to Wendy Stevens, MSN CRNP-BC, by phone at 215/923-4923 or by e-mail at email@example.com. She is a surgical critical care nurse practitioner at the Hospital of the University of Pennsylvania, Philadelphia, PA.
|Printer friendly Cite/link Email Feedback|
|Author:||Stevens, Wendy J.|
|Publication:||Journal of Neuroscience Nursing|
|Date:||Dec 1, 2004|
|Previous Article:||West Nile virus--the eye of the storm: a case study.|
|Next Article:||Dexamethasone therapy in patients with brain tumors--a focus on tapering.|